Lobbying client

STRONGBRIDGE BIOPHARMA, PLC

Biotechnology manufacturer

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
18
Filed by
2
Reported in-house
—
Reported by firms
$810,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2018 to 2020

Filings

18 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2020
BAKER & HOSTETLER LLP $60,000 reported
1st Quarter - Report
1st Quarter 2020
BAKER & HOSTETLER LLP $60,000 reported
4th Quarter - Report
4th Quarter 2019
BAKER & HOSTETLER LLP $60,000 reported
3rd Quarter - Report
3rd Quarter 2019
BAKER & HOSTETLER LLP $60,000 reported
2nd Quarter - Report
2nd Quarter 2019
BAKER & HOSTETLER LLP $60,000 reported
1st Quarter - Report
1st Quarter 2019
BAKER & HOSTETLER LLP $60,000 reported
1st Quarter - Termination (No Activity)
1st Quarter 2019
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP — reported
4th Quarter - Report
4th Quarter 2018
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP — reported
4th Quarter - Report
4th Quarter 2018
BAKER & HOSTETLER LLP $60,000 reported
3rd Quarter - Report
3rd Quarter 2018
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
BAKER & HOSTETLER LLP 10 $600,000
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP 5 $210,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 16

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.